Mammalian model of a malignant disorder
US5684221A · kind A · utility
0Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 12, 1994 |
| Grant date | Nov 4, 1997 |
| Priority date | — |
| Expiry date | May 12, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01K2267/0331
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for producing a mouse having a systemic malignant disease which mimics a human IL-2 expressing. T-cell malignancy, which includes administering to a mouse a mixture of passaged cells comprising cancer causing cells, the mixture having been rendered cancer causing by in vivo passage of tumor inducing cells in athymic mice.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.